1
|
Affiliation(s)
- M. Marani
- Nephrology and Dialysis Unit “San Salvatore” Hospital P.le Cinelli 4 61100 Pesaro, Italy
| | - F. Manenti
- Nephrology and Dialysis Unit “San Salvatore” Hospital P.le Cinelli 4 61100 Pesaro, Italy
| | - M. Di Luca
- Nephrology and Dialysis Unit “San Salvatore” Hospital P.le Cinelli 4 61100 Pesaro, Italy
| | - R. Cecchini
- Nephrology and Dialysis Unit “San Salvatore” Hospital P.le Cinelli 4 61100 Pesaro, Italy
| | - M. Martello
- Nephrology and Dialysis Unit “San Salvatore” Hospital P.le Cinelli 4 61100 Pesaro, Italy
| | - K. Kulurianu
- Nephrology and Dialysis Unit “San Salvatore” Hospital P.le Cinelli 4 61100 Pesaro, Italy
| |
Collapse
|
2
|
Marinello PC, Cella P, Testa M, Guirro P, Brito W, Borges F, Cecchini R, Cecchini A, Duarte J, Deminice R. Creatine supplementation exacerbates ethanol-induced hepatic damage in mice. Nutrition 2019; 66:122-130. [DOI: 10.1016/j.nut.2019.05.004] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2019] [Revised: 05/02/2019] [Accepted: 05/26/2019] [Indexed: 02/08/2023]
|
3
|
Lemos LGT, Victorino VJ, Herrera ACSA, Aranome AMF, Cecchini AL, Simão ANC, Panis C, Cecchini R. Trastuzumab-based chemotherapy modulates systemic redox homeostasis in women with HER2-positive breast cancer. Int Immunopharmacol 2015; 27:8-14. [PMID: 25937481 DOI: 10.1016/j.intimp.2015.04.037] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/09/2015] [Revised: 04/07/2015] [Accepted: 04/17/2015] [Indexed: 12/22/2022]
Abstract
Trastuzumab is an immunotargeting therapeutic against breast tumors with amplification of the human epithelial growth factor receptor 2 (HER2). HER2 patients naturally exhibit disruption in the pro-oxidant inflammatory profiling; however, the impact of trastuzumab-based chemotherapy in modulating this process is still unknown. Here we determined the systemic pro-inflammatory profile of women diagnosed with HER2-amplified tumors, undergoing trastuzumab-based chemotherapy (TZ), and compared the results with that of healthy controls (CTR) and untreated patients with HER2-amplified breast cancer (CA). The plasmatic inflammatory profile was assessed by evaluating pro-oxidant parameters such as lipid peroxidation, total antioxidant capacity (TRAP), levels of advanced oxidation protein products (AOPPs), nitric oxide (NO), C-reactive protein (CRP), and total thiol content. Markers of cardiac damage were also assessed. Our findings showed increased NO levels in TZ than that in either CA or CTR groups. Furthermore, TZ augmented TRAP and reduced total thiol than that of the CA group. Our data also revealed that AOPP levels were significantly higher in the TZ than the CA group. AOPP and the MB fraction of creatine-kinase (CKMB) levels were positively correlated in TZ patients. These findings suggest that trastuzumab-associated chemotherapy can modulate the pro-inflammatory markers of HER2-positive breast cancer patients to the levels found in healthy controls.
Collapse
Affiliation(s)
- L G T Lemos
- Bone Marrow Transplantation Center, National Cancer Institute, INCA, Rio de Janeiro, Brazil
| | - V J Victorino
- Faculty of Medicine, University of São Paulo, USP, São Paulo, Brazil
| | - A C S A Herrera
- Bone Marrow Transplantation Center, National Cancer Institute, INCA, Rio de Janeiro, Brazil
| | - A M F Aranome
- Laboratory of Physiopathology and Free Radicals, Londrina State University, UEL, Londrina, Paraná, Brazil
| | - A L Cecchini
- Laboratory of Physiopathology and Free Radicals, Londrina State University, UEL, Londrina, Paraná, Brazil
| | - A N C Simão
- Universitary Hospital, Department of Pharmacy, State University of Londrina, Londrina, Paraná, Brazil
| | - C Panis
- Laboratory of Inflammatory Mediators, State University of West Paraná, UNIOESTE, Francisco Beltrão, Paraná, Brazil.
| | - R Cecchini
- Laboratory of Physiopathology and Free Radicals, Londrina State University, UEL, Londrina, Paraná, Brazil
| |
Collapse
|
4
|
Terra VA, Souza-Neto FP, Frade MAC, Ramalho LNZ, Andrade TAM, Pasta AAC, Conchon AC, Guedes FA, Luiz RC, Cecchini R, Cecchini AL. Genistein prevents ultraviolet B radiation-induced nitrosative skin injury and promotes cell proliferation. J Photochem Photobiol B 2015; 144:20-7. [PMID: 25668145 DOI: 10.1016/j.jphotobiol.2015.01.013] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/23/2014] [Revised: 01/21/2015] [Accepted: 01/22/2015] [Indexed: 01/21/2023]
Abstract
Nitric oxide (NO) levels increase considerably after 24h of exposure of skin to ultraviolet B (UVB) radiation, which leads to nitrosative skin injury. In addition, increased NO levels after exposure to UVB radiation are associated with inhibition of cell proliferation. Compared to the UV-control group, UV-genistein at 10 mg/kg (UV-GEN10) group showed tissue protection, decreased lipid peroxide and nitrotyrosine formation, and low CAT activity. Furthermore, NO levels and iNOS labeling remained high. In this group, the reduction in lipid peroxides and nitrotyrosine was accompanied by upregulation of cell proliferation factors (Ki67 and PCNA), which indicated that prevention of nitrosative skin injury promoted cell proliferation and DNA repair. Genistein also prevented nitrosative events, inhibited ONOO(-) formation, which leads to tissue protection and cell proliferation. The UV-GEN15 group did not result in a greater protective effect compared to that with UV-GEN10 group. In the UV-GEN15 group, histological examination of the epidermis showed morphological alterations without efficient protection against lipid peroxide formation, as well as inhibition of Ki67 and PCNA, and VEGF labeling, which suggested inhibition of cell proliferation. These results help to elucidate the mechanisms underlying the photoprotective effect of genistein and reveal the importance of UVB radiation-induced nitrosative damage.
Collapse
Affiliation(s)
- V A Terra
- Laboratorio de Patologia Molecular, Universidade Estadual de Londrina, Rod. Celso Garcia Cid, PR-445, km 380, 86051-990 Londrina, PR, Brazil
| | - F P Souza-Neto
- Laboratorio de Patologia Molecular, Universidade Estadual de Londrina, Rod. Celso Garcia Cid, PR-445, km 380, 86051-990 Londrina, PR, Brazil; Laboratorio de Patofisiologia e Radicais Livres, Universidade Estadual de Londrina, Rod. Celso Garcia Cid, PR-445, km 380, 86051-990 Londrina, PR, Brazil
| | - M A C Frade
- Departamento de Clínica Medica, Divisão de Dermatologia, Universidade de São Paulo, Ribeirão Preto, SP, Brazil
| | - L N Z Ramalho
- Departamento de Patologia e Medicina Legal, Universidade de São Paulo, Ribeirão Preto, SP, Brazil
| | - T A M Andrade
- Departamento de Clínica Medica, Divisão de Dermatologia, Universidade de São Paulo, Ribeirão Preto, SP, Brazil
| | - A A C Pasta
- Laboratorio de Patologia Molecular, Universidade Estadual de Londrina, Rod. Celso Garcia Cid, PR-445, km 380, 86051-990 Londrina, PR, Brazil
| | - A C Conchon
- Laboratorio de Patologia Molecular, Universidade Estadual de Londrina, Rod. Celso Garcia Cid, PR-445, km 380, 86051-990 Londrina, PR, Brazil
| | - F A Guedes
- Departamento de Patologia e Medicina Legal, Universidade de São Paulo, Ribeirão Preto, SP, Brazil
| | - R C Luiz
- Laboratorio de Patologia Molecular, Universidade Estadual de Londrina, Rod. Celso Garcia Cid, PR-445, km 380, 86051-990 Londrina, PR, Brazil
| | - R Cecchini
- Laboratorio de Patofisiologia e Radicais Livres, Universidade Estadual de Londrina, Rod. Celso Garcia Cid, PR-445, km 380, 86051-990 Londrina, PR, Brazil
| | - A L Cecchini
- Laboratorio de Patologia Molecular, Universidade Estadual de Londrina, Rod. Celso Garcia Cid, PR-445, km 380, 86051-990 Londrina, PR, Brazil; Laboratorio de Patofisiologia e Radicais Livres, Universidade Estadual de Londrina, Rod. Celso Garcia Cid, PR-445, km 380, 86051-990 Londrina, PR, Brazil.
| |
Collapse
|
5
|
Borges FH, Marinello PC, Cecchini AL, Blegniski FP, Guarnier FA, Cecchini R. Oxidative and proteolytic profiles of the right and left heart in a model of cancer-induced cardiac cachexia. ACTA ACUST UNITED AC 2014; 21:257-65. [PMID: 24996969 DOI: 10.1016/j.pathophys.2014.05.003] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/21/2014] [Revised: 05/05/2014] [Accepted: 05/08/2014] [Indexed: 01/29/2023]
Abstract
Cardiac cachexia is a syndrome that has received increased attention in recent years. Although an association between proteolysis and cardiac cachexia has been proposed, the direct influence of oxidative stress on the process has not been demonstrated. In the present study, the right (RH) and left (LH) hearts (atrium and ventricle of each side of the heart) were collected from rats at the 5th and 10th days after phosphate buffer (control) orWalker-256 solid tumour implantation. Immediately after sacrifice, cachexia was determined in tumour-bearing animals by the formula: [(inicial body weight-final body weight+tumour weight+weight gain of control group)/(initial body weight+body mass gain of control group)]×100%; RH and LH were stored until use. Oxidative stress and proteolysis were determined in each collected sample. In addition, heart samples were collected from a separate set of animals to determine the thickness of the left and right ventricles. Cachexia values increased over time after tumour implantation from 6.85% at the 5th day to 17.76% at the 10th day. There was no significant difference in LH wet weight and ventricle thickness compared with the control, where as RH wet weight (0.109±0.09g at the 5th day and 0.093±0.09g at the 10th day) and thickness (420±16μm at the 5th day and 279±08μm at the 10th day) were significantly decreased at both time points when compared with control values (0.153±0.06g and 607±21μm, respectively). tert-Butyl-stimulated chemiluminescence analysis revealed a significant increase in the LH and decrease in the RH oxidative stress profiles. Carbonylated proteins increased in the LH (140%, p<0.05) and RH (100%, p<0.05) at the 5th day, and significantly decreased in both sides on the 10th day compared to controls. Chemotrypsin-like, caspase-like, and calpain-like activities were evaluated by chemiluminescence, and only calpain-like activity was found to increase at the 5th day in the RH. In the LH, all proteolytic activities systems were decreased when compared with controls. Together, these results demonstrate that oxidative stress appears to play a different role in mass modulation on the LH and RH. The proteolytic systems evaluated herein also appear to have different effects on the responses developed during cardiac cachexia in the two sides of the heart.
Collapse
Affiliation(s)
- F H Borges
- Laboratory of Pathophysiology and Free Radicals, Department of General Pathology, Rodovia Celso Garcia Cid, PR445, km 380, Campus Universitário, Londrina 86051-990, Brazil.
| | - P C Marinello
- Laboratory of Molecular Pathology, Department of General Pathology, Rodovia Celso Garcia Cid, PR445, km 380, Campus Universitário, Londrina 86051-990, Brazil.
| | - A L Cecchini
- Laboratory of Molecular Pathology, Department of General Pathology, Rodovia Celso Garcia Cid, PR445, km 380, Campus Universitário, Londrina 86051-990, Brazil.
| | - F P Blegniski
- Laboratory of Pathophysiology and Muscle Adaptation, Department of General Pathology, Rodovia Celso Garcia Cid, PR445, km 380, Campus Universitário, Londrina 86051-990, Brazil.
| | - F A Guarnier
- Laboratory of Pathophysiology and Muscle Adaptation, Department of General Pathology, Rodovia Celso Garcia Cid, PR445, km 380, Campus Universitário, Londrina 86051-990, Brazil.
| | - R Cecchini
- Laboratory of Pathophysiology and Free Radicals, Department of General Pathology, Rodovia Celso Garcia Cid, PR445, km 380, Campus Universitário, Londrina 86051-990, Brazil.
| |
Collapse
|
6
|
Panis C, Herrera ACSA, Aranome AMF, Victorino VJ, Michelleti PL, Morimoto HK, Cecchini AL, Simão ANC, Cecchini R. Clinical insights from adiponectin analysis in breast cancer patients reveal its anti-inflammatory properties in non-obese women. Mol Cell Endocrinol 2014; 382:190-196. [PMID: 24095646 DOI: 10.1016/j.mce.2013.09.030] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/03/2013] [Accepted: 09/24/2013] [Indexed: 11/20/2022]
Abstract
Adiponectin is a cytokine reported as a determinant of poor prognosis in women with breast cancer. However, because data regarding its role in breast cancer have been obtained primarily from studies employing overweight or obese women, the adiponectin profile in non-obese women is poorly understood. In this study, we determined adiponectin levels in plasma from non-obese women with breast cancer and investigated a possible correlation with systemic inflammatory status. We determined the plasma adiponectin levels as well as biochemical and oxidative stress parameters in 80 women. Our results revealed that plasma adiponectin levels were affected by chemotherapy, estrogen receptor status, and disease progression. Adiponectin was positively correlated with antioxidant levels, without affecting either the metastatic behavior of disease or patient outcome. These findings highlight adiponectin as a novel player in the endocrine signaling that modulates the oxidative inflammatory response in human breast cancer, and contribute to the understanding of the role of adiponectin in pathological conditions in non-obese women.
Collapse
Affiliation(s)
- C Panis
- Laboratory of Physiopathology and Free Radicals, Department of General Pathology, State University of Londrina, Londrina, Paraná, Brazil.
| | - A C S A Herrera
- Laboratory of Physiopathology and Free Radicals, Department of General Pathology, State University of Londrina, Londrina, Paraná, Brazil
| | - A M F Aranome
- Laboratory of Physiopathology and Free Radicals, Department of General Pathology, State University of Londrina, Londrina, Paraná, Brazil
| | | | - P L Michelleti
- Laboratory of Physiopathology and Free Radicals, Department of General Pathology, State University of Londrina, Londrina, Paraná, Brazil
| | - H K Morimoto
- Universitary Hospital, Department of Pharmacy, State University of Londrina, Londrina, Paraná, Brazil
| | - A L Cecchini
- Laboratory of Physiopathology and Free Radicals, Department of General Pathology, State University of Londrina, Londrina, Paraná, Brazil
| | - A N C Simão
- Universitary Hospital, Department of Pharmacy, State University of Londrina, Londrina, Paraná, Brazil
| | - R Cecchini
- Laboratory of Physiopathology and Free Radicals, Department of General Pathology, State University of Londrina, Londrina, Paraná, Brazil
| |
Collapse
|
7
|
Lozovoy MAB, Simão ANC, Morimoto HK, Iryioda TMV, Panis C, Reiche EMV, Borelli SD, Oliveira SR, Cecchini R, Dichi I. Hypertension is associated with serologically active disease in patients with systemic lupus erythematosus: role of increased Th1/Th2 ratio and oxidative stress. Scand J Rheumatol 2013; 43:59-62. [PMID: 24134304 DOI: 10.3109/03009742.2013.834963] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
OBJECTIVES To determine whether disease activity verified by laboratorial parameters is associated with a higher frequency of hypertension in patients with systemic lupus erythematosus (SLE) without renal impairment and to investigate factors that could influence this hypertension. METHOD This study included 102 controls, 70 patients with inactive SLE, and 53 patients with active SLE without renal impairment. We evaluated T helper type 1 (Th1)/Th2 lineage cytokines, nitric oxide (NO), insulin resistance (IR), and oxidative stress. RESULTS Patients with active SLE had a higher probability of developing hypertension compared to controls [odds ratio (OR) 3.833, 95% confidence interval (CI) 1.806-8.137, p < 0.0003] and patients with inactive SLE (OR 2.215, 95% CI 1.032-4.752, p = 0.0394). Active SLE patients had a higher interleukin (IL)-12/IL-4 ratio (p < 0.05) than both controls and inactive SLE patients. Protein oxidation was significantly higher in patients with active SLE than in the control group and in patients with inactive SLE (p < 0.01 and p < 0.05, respectively). Multivariate analysis revealed an association between the presence of hypertension and he levels of glucose (p = 0.0276), insulin (p = 0.0498), hydroperoxides (p = 0.0221), IFN-γ (p = 0.0494), IL-17 (p = 0.0272), IL-12/IL-10 (p = 0.0373), IFN-γ/IL-10 (p = 0.0142), IFN-γ/IL-4 (p = 0.0320), and adiponectin (p = 0.0433). CONCLUSIONS Patients with active SLE without renal impairment had an increased frequency of high blood pressure (43.4%) compared with patients with inactive SLE (25.7%) and controls (16.7%). Hypertension was associated with serologically active disease and was influenced by an increased Th1/Th2 ratio and oxidative stress.
Collapse
Affiliation(s)
- M A B Lozovoy
- Department of Clinical Analysis, University of North Paraná (UNOPAR) , Londrina, Paraná , Brazil
| | | | | | | | | | | | | | | | | | | |
Collapse
|
8
|
Victorino VJ, Panis C, Campos FC, Cayres RC, Colado-Simão AN, Oliveira SR, Herrera ACSA, Cecchini AL, Cecchini R. Decreased oxidant profile and increased antioxidant capacity in naturally postmenopausal women. Age (Dordr) 2013; 35:1411-21. [PMID: 22645022 PMCID: PMC3705106 DOI: 10.1007/s11357-012-9431-9] [Citation(s) in RCA: 52] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/14/2012] [Accepted: 05/15/2012] [Indexed: 05/15/2023]
Abstract
Recent works have shown a dual side of estrogens, and research on the relationship between oxidative stress and menopausal status remains unclear and has produced controversial results. In this work, we aimed to evaluate by sensitive methods the oxidant and antioxidant changes that develop after natural menopause. Thirty premenopausal and 28 naturally postmenopausal women volunteered for this study. Blood was collected and plasma used. 17-OH estradiol levels in plasma were estimated. Plasma levels of advanced oxidation protein products (AOPP), lipid peroxidation products (such as hydroperoxides and malondialdehyde (MDA)), and nitrites were measured, and total radical antioxidant parameter testing was performed to determine the oxidant and antioxidant profiles, respectively. Estrogen levels were significantly increased (p < 0.02) in premenopausal women (54.28 ± 9.34 pg/mL) as compared with postmenopausal women (18.10 ± 1.49 pg/mL). Postmenopausal women had lower levels of lipid hydroperoxide oxidation (p < 0.0001), lipid hydroperoxide levels evaluated by the area under the curve (AUC; 1,366,000 ± 179,400 AUC; p < 0.01), and hydroperoxides as measured by the ferrous oxidation-xylenol orange method (31.48 ± 2.7 μM; p < 0.0001). The MDA levels did not differ between pre- and postmenopausal women whether measured by thiobarbituric acid-reactive substances or high-performance liquid chromatography assays. No differences in AOPP and nitrite levels were observed between pre- and postmenopausal women. Postmenopausal women also exhibited a higher total radical antioxidant level (0.89 ± 0.08 μM Trolox; p < 0.0001). Postmenopausal women demonstrated lower levels of oxidative damage and a higher antioxidant capacity than premenopausal women.
Collapse
Affiliation(s)
- V J Victorino
- Laboratory of Pathophysiology and Free Radicals, Department of General Pathology, State University of Londrina, 86051-990, Londrina, Paraná, Brazil.
| | | | | | | | | | | | | | | | | |
Collapse
|
9
|
Lozovoy MAB, Simão ANC, Oliveira SR, Iryioda TMV, Panis C, Cecchini R, Dichi I. Relationship between iron metabolism, oxidative stress, and insulin resistance in patients with systemic lupus erythematosus. Scand J Rheumatol 2013; 42:303-10. [PMID: 23424997 DOI: 10.3109/03009742.2012.754942] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
OBJECTIVE The aim of the present study was to assess oxidative stress and iron metabolism in systemic lupus erythematosus (SLE) patients with and without insulin resistance (IR). METHOD This study included 236 subjects (125 controls and 111 SLE patients). Patients with SLE were divided in two groups: with (n = 72) or without (n = 39) IR. RESULTS SLE patients with IR showed higher advanced oxidation protein product (AOPP) levels (p = 0.030) and gamma-glutamyltransferase (GGT) levels (p = 0.001) and lower sulfhydryl groups of proteins (p = 0.0002) and total radical-trapping antioxidant parameter (TRAP) corrected by uric acid (UA) levels (p = 0.04) when compared to SLE patients without IR. However, SLE patients with IR presented lower serum 8-isoprostane (p = 0.05) and carbonyl protein levels (p = 0.04) when compared to SLE patients without IR. Serum ferritin levels were significantly higher in SLE patients (p = 0.0006) than in controls, and SLE patients with IR presented higher serum ferritin levels (p = 0.01) than SLE patients without IR. Patients with SLE showed that IR was inversely correlated to TRAP/UA (r = -0.2724, p = 0.0008) and serum ferritin was positively correlated to AOPP (r = 0.2870, p = 0.004). CONCLUSIONS This study found that oxidative stress was higher in the group of SLE patients with IR, and increased ferritin, whether caused by the inflammatory process per se or hyperinsulinaemia, can favour the redox process. In addition, the preset data reinforce the need to measure oxidative stress with several methodologies with different assumptions.
Collapse
Affiliation(s)
- M A B Lozovoy
- Department of Clinical Analysis, University North of Paraná (UNOPAR), Paraná, Brazil
| | | | | | | | | | | | | |
Collapse
|
10
|
Herrera ACSA, Panis C, Victorino VJ, Campos FC, Colado-Simão AN, Cecchini AL, Cecchini R. Molecular subtype is determinant on inflammatory status and immunological profile from invasive breast cancer patients. Cancer Immunol Immunother 2012; 61:2193-201. [PMID: 22618884 PMCID: PMC11028631 DOI: 10.1007/s00262-012-1283-8] [Citation(s) in RCA: 36] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/07/2012] [Accepted: 05/03/2012] [Indexed: 10/28/2022]
Abstract
Breast cancer consists in a chronic inflammatory disease with multiple biological and clinical behaviors. Based on high throughput technologies data, this disease is currently classified according to the molecular expression of estrogen (ER), progesterone (PR) and human epidermal growth factor (HER-2) receptors. In this study, we defined the inflammatory profile of the main molecular subtypes of breast cancer patients: luminal (ER and PR positive, HER-2 negative), HER-2 enriched (HER-2 positive) and triple negative (ER, PR and HER-2 negative). Cytokines panel was assessed by measurement of TNF-α, TGF-β, IL-1, IL-10 and IL-12 plasmatic levels. Oxidative profile was assessed by determination of lipid peroxidation, total antioxidant capacity of plasma, malondialdehyde levels, carbonyl content and nitric oxide (NO). Clinical data were correlated with inflammatory findings. Our findings demonstrated that patients bearing the luminal subtype displayed high TNF-α, TGF-β and enhanced oxidative stress levels associated with reduced IL-12. HER-2-enriched group exhibited higher levels of TNF-α, IL-12 and TGF-β associated with enhanced oxidative stress. Triple-negative subtype exhibited the most aggressive profile of disease behavior, with reduction in both TNF-α and TGF-β, with high levels of lipid peroxidation and NO. The clinical importance of our findings lies in the fact that the inflammatory status varies in distinct ways due to molecular subtype of breast cancer, opening potential therapeutic targets to future therapies.
Collapse
Affiliation(s)
- A. C. S. A. Herrera
- Laboratory of Pathophysiology and Free Radicals, Department of General Pathology, Center of Biological Sciences, State University of Londrina, Londrina, 86051-990 Brazil
| | - C. Panis
- Laboratory of Pathophysiology and Free Radicals, Department of General Pathology, Center of Biological Sciences, State University of Londrina, Londrina, 86051-990 Brazil
| | - V. J. Victorino
- Laboratory of Pathophysiology and Free Radicals, Department of General Pathology, Center of Biological Sciences, State University of Londrina, Londrina, 86051-990 Brazil
| | - F. C. Campos
- Laboratory of Pathophysiology and Free Radicals, Department of General Pathology, Center of Biological Sciences, State University of Londrina, Londrina, 86051-990 Brazil
| | - A. N. Colado-Simão
- Laboratory of Pathophysiology and Free Radicals, Department of General Pathology, Center of Biological Sciences, State University of Londrina, Londrina, 86051-990 Brazil
| | - A. L. Cecchini
- Laboratory of Pathophysiology and Free Radicals, Department of General Pathology, Center of Biological Sciences, State University of Londrina, Londrina, 86051-990 Brazil
| | - R. Cecchini
- Laboratory of Pathophysiology and Free Radicals, Department of General Pathology, Center of Biological Sciences, State University of Londrina, Londrina, 86051-990 Brazil
| |
Collapse
|
11
|
Terra V, Souza-Neto F, Pereira R, Silva T, Costa A, Luiz R, Cecchini R, Cecchini A. Time-dependent reactive species formation and oxidative stress damage in the skin after UVB irradiation. Journal of Photochemistry and Photobiology B: Biology 2012; 109:34-41. [DOI: 10.1016/j.jphotobiol.2012.01.003] [Citation(s) in RCA: 42] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/18/2011] [Revised: 01/17/2012] [Accepted: 01/19/2012] [Indexed: 10/14/2022]
|
12
|
Panis C, Lemos LGT, Victorino VJ, Herrera ACSA, Campos FC, Colado Simão AN, Pinge-Filho P, Cecchini AL, Cecchini R. Immunological effects of taxol and adryamicin in breast cancer patients. Cancer Immunol Immunother 2012; 61:481-8. [PMID: 21959683 PMCID: PMC11028662 DOI: 10.1007/s00262-011-1117-0] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/11/2011] [Accepted: 09/15/2011] [Indexed: 12/16/2022]
Abstract
Antineoplastic chemotherapy still consists in the major first-line therapeutics against cancer. Several reports have described the immunomodulatory effects of these drugs based on in vitro treatment, but no previous data are known about these effects in patients and its association with immunological-mediated toxicity. In this study, we first characterize the immunological profile of advanced breast cancer patients treated with doxorubicin and paclitaxel protocols, immediately after chemotherapy infusion. Our findings included an immediate plasmatic reduction in IL-1, IL-10, and TNF-α levels in doxorubicin-treated patients, as well as high levels of IL-10 in paclitaxel patients. Further, it was demonstrated that both drugs led to leukocytes oxidative burst impairment. In vitro analysis was performed exposing healthy blood to both chemotherapics in the same concentration and time of exposition of patients, resulting in low IL-10 and high IL-1β in doxorubicin exposition, as low TNF-α and high IL-1 in paclitaxel treatment. Nitric oxide levels were not altered in both in vivo and in vitro treatments. In conclusion, our data revealed for the first time that the immediate effects of chemotherapy could be mediated by cytokines signaling in patients and that the results observed in patients could be a resultant of host immune cells activation.
Collapse
Affiliation(s)
- C Panis
- Laboratory of Physiopathology and Free Radicals, Department of General Pathology-Center of Biological Science, State University of Londrina, Londrina, 86051-990, Brazil.
| | | | | | | | | | | | | | | | | |
Collapse
|
13
|
Lozovoy MAB, Simão ANC, Hohmann MSN, Simão TNC, Barbosa DS, Morimoto HK, Reiche EMV, Cecchini R, Dichi I. Inflammatory biomarkers and oxidative stress measurements in patients with systemic lupus erythematosus with or without metabolic syndrome. Lupus 2011; 20:1356-64. [PMID: 21868433 DOI: 10.1177/0961203311411348] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/30/2023]
Abstract
The aims of the present study were to report the frequency of metabolic syndrome in systemic lupus erythematosus (SLE); to verify differences in inflammatory biomarkers and oxidative stress in SLE patients with or without metabolic syndrome; and to assess which metabolic syndrome components are associated with oxidative stress and disease activity. The study included 58 SLE patients and 105 controls. SLE patients were divided in two groups, with and without metabolic syndrome. 41.4% patients met the criteria for metabolic syndrome compared with 10.5% controls. Patients with SLE and metabolic syndrome had significantly raised serum uric acid, C-reactive protein (CRP), lipid hydroperoxides, and protein oxidation when compared with patients with SLE without metabolic syndrome. Lipid hydroperoxides were correlated with CRP, whereas protein oxidation was associated with waist circumference and uric acid. There was a positive association between serum C3 and C4 and glucose and between C3 and CRP. SLE disease activity index (SLEDAI) scores were positively correlated with body mass index (BMI) and waist circumference (WC). In conclusion, SLE patients have a high prevalence of metabolic syndrome and this syndrome directly contributes to increase inflammatory status and oxidative stress. Inflammatory processes, being overweight/obese, and uric acid may favor oxidative stress increases in patients with SLE and metabolic syndrome. C3 and C4 may have a positive acute-phase protein behavior in patients with SLE.
Collapse
Affiliation(s)
- M A B Lozovoy
- Department of Clinical Analysis, University North of Paraná (UNOPAR), Londrina, Brazil
| | | | | | | | | | | | | | | | | |
Collapse
|
14
|
Cabibbo M, Ricci P, Cecchini R, Rymuza Z, Sullivan J, Dub S, Cohen S. An international round-robin calibration protocol for nanoindentation measurements. Micron 2011; 43:215-22. [PMID: 21890366 DOI: 10.1016/j.micron.2011.07.016] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/17/2011] [Revised: 07/26/2011] [Accepted: 07/26/2011] [Indexed: 10/17/2022]
Abstract
Nanoindentation has become a common technique for measuring the hardness and elastic-plastic properties of materials, including coatings and thin films. In recent years, different nanoindenter instruments have been commercialised and used for this purpose. Each instrument is equipped with its own analysis software for the derivation of the hardness and reduced Young's modulus from the raw data. These data are mostly analysed through the Oliver and Pharr method. In all cases, the calibration of compliance and area function is mandatory. The present work illustrates and describes a calibration procedure and an approach to raw data analysis carried out for six different nanoindentation instruments through several round-robin experiments. Three different indenters were used, Berkovich, cube corner, spherical, and three standardised reference samples were chosen, hard fused quartz, soft polycarbonate, and sapphire. It was clearly shown that the use of these common procedures consistently limited the hardness and reduced the Young's modulus data spread compared to the same measurements performed using instrument-specific procedures. The following recommendations for nanoindentation calibration must be followed: (a) use only sharp indenters, (b) set an upper cut-off value for the penetration depth below which measurements must be considered unreliable, (c) perform nanoindentation measurements with limited thermal drift, (d) ensure that the load-displacement curves are as smooth as possible, (e) perform stiffness measurements specific to each instrument/indenter couple, (f) use Fq and Sa as calibration reference samples for stiffness and area function determination, (g) use a function, rather than a single value, for the stiffness and (h) adopt a unique protocol and software for raw data analysis in order to limit the data spread related to the instruments (i.e. the level of drift or noise, defects of a given probe) and to make the H and E(r) data intercomparable.
Collapse
Affiliation(s)
- M Cabibbo
- Dipartimento di Ingegneria Industriale e Scienze Matematiche, Università Politecnica delle Marche, Via Brecce Bianche, 60131 Ancona, Italy.
| | | | | | | | | | | | | |
Collapse
|
15
|
Lozovoy MAB, Simão ANC, Panis C, Rotter MAC, Reiche EMV, Morimoto HK, Lavado E, Cecchini R, Dichi I. Oxidative stress is associated with liver damage, inflammatory status, and corticosteroid therapy in patients with systemic lupus erythematosus. Lupus 2011; 20:1250-9. [PMID: 21813592 DOI: 10.1177/0961203311411350] [Citation(s) in RCA: 40] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
Oxidative stress exerts an important role on the pathophysiological mechanisms of systemic lupus erythematosus (SLE). This study investigated oxidative stress in patients with SLE and its correlation with disease activity, corticosteroid therapy, and liver function biomarkers. The study included 58 patients with SLE and 105 healthy volunteers. Patients showed oxidative stress increase evaluated by tert-butyl hydroperoxide-initiated chemiluminescence (CL-LOOH), advanced oxidation protein products (AOPP), and nitric oxide metabolites. C-reactive protein (CRP) was associated with CL-LOOH and with AOPP. Aspartate aminotransferase correlated significantly with CL-LOOH and with AOPP. Patients with disease activity showed an inverse significant correlation of daily prednisone doses and CL-LOOH and a direct correlation with total antioxidant capacity. In conclusion, patients with SLE have persistent lipoperoxidation and protein oxidation even with inactive disease or mild disease activity. The significant correlation between oxidative stress and CRP suggests that, despite clinical remission, the persistence of an inflammatory condition favors oxidative stress. Oxidative stress was associated with liver enzymes, and this relationship seems to support the hypothesis of drug-induced oxidative stress with consequent liver injury. In relation to non-active disease, patients with active SLE did not present oxidative stress and antioxidant capacity changes, due to the antioxidant drugs used in SLE treatment, especially prednisone.
Collapse
Affiliation(s)
- M A B Lozovoy
- Department of Clinical Analysis, University North of Paraná (UNOPAR), Londrina, Brazil
| | | | | | | | | | | | | | | | | |
Collapse
|
16
|
Simão A, Lozovoy M, Simão T, Venturini D, Barbosa D, Dichi J, Matsuo T, Cecchini R, Dichi I. Immunological and biochemical parameters of patients with metabolic syndrome and the participation of oxidative and nitroactive stress. Braz J Med Biol Res 2011. [DOI: 10.1590/s0100-879x2011000700015] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
|
17
|
Simão A, Lozovoy M, Simão T, Venturini D, Barbosa D, Dichi J, Matsuo T, Cecchini R, Dichi I. Immunological and biochemical parameters of patients with metabolic syndrome and the participation of oxidative and nitroactive stress. Braz J Med Biol Res 2011; 44:707-12. [DOI: 10.1590/s0100-879x2011007500069] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/17/2010] [Accepted: 05/13/2011] [Indexed: 11/21/2022] Open
Affiliation(s)
| | | | | | | | | | | | | | | | - I. Dichi
- Universidade Estadual de Londrina
| |
Collapse
|
18
|
Peres P, Terra V, Guarnier F, Cecchini R, Cecchini A. Photoaging and chronological aging profile: Understanding oxidation of the skin. Journal of Photochemistry and Photobiology B: Biology 2011; 103:93-7. [DOI: 10.1016/j.jphotobiol.2011.01.019] [Citation(s) in RCA: 72] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/22/2010] [Revised: 12/21/2010] [Accepted: 01/21/2011] [Indexed: 01/09/2023]
|
19
|
Cunha NV, de Abreu SB, Panis C, Grassiolli S, Guarnier FA, Cecchini R, Mazzuco TL, Pinge-Filho P, Martins-Pinge MC. Cox-2 inhibition attenuates cardiovascular and inflammatory aspects in monosodium glutamate-induced obese rats. Life Sci 2010; 87:375-81. [PMID: 20688085 DOI: 10.1016/j.lfs.2010.07.014] [Citation(s) in RCA: 34] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/10/2010] [Revised: 07/18/2010] [Accepted: 07/20/2010] [Indexed: 12/31/2022]
Abstract
AIMS the purpose of the present work was to investigate the effect of cyclooxygenase-2 (COX-2) inhibition on the cardiovascular and inflammatory aspects promoted by monosodium glutamate (MSG)-induced obesity in rats. MAIN METHODS Neonatal Wistar male rats were injected with MSG (4 mg/g body weight ID) or equimolar saline (control). Treatment with celecoxib (50 mg/kg ip) or saline (0.9% NaCl ip) began at 60 days of age. At 90 days, all rats were anesthetized for catheterization of the femoral artery, and the mean arterial pressure (MAP) and heart rate (HR) were recorded once consciousness was regained. KEY FINDINGS MSG obese rats were hypertensive (MAP=138±4 mm Hg) compared with controls (MAP=118±2 mm Hg). After treatment with celecoxib, the hypertension was attenuated (MAP=126±2 mm Hg) in obese rats without changes in HR. The retroperitoneal and periepididymal fat weighed more in obese rats (Obese: Retro=7.08±0.51, Peri=6.36±0.81, CONTROL: Retro=3.60±0.46; Peri=3.24±0.42), but celecoxib did not alter these parameters. Plasma nitric oxide levels were not different between groups. However, the level of plasma prostaglandins, the immunohistochemical staining of COX-2 in cardiac tissue and plasma lipoperoxidation were higher in obese rats, and celecoxib attenuated these parameters. MSG produced liver steatosis that was also attenuated following celecoxib treatment. SIGNIFICANCE Our data demonstrate an association between increased blood pressure and products of COX-2 in obese rats, suggesting a role for prostaglandins in the hypertensive and inflammatory aspects of MSG-induced obesity.
Collapse
Affiliation(s)
- N V Cunha
- Department of Physiological Sciences, State University of Londrina, Londrina, Paraná, Brazil
| | | | | | | | | | | | | | | | | |
Collapse
|
20
|
Casado MF, Cecchini AL, Simão ANC, Oliveira RD, Cecchini R. Free radical-mediated pre-hemolytic injury in human red blood cells subjected to lead acetate as evaluated by chemiluminescence. Food Chem Toxicol 2007; 45:945-52. [PMID: 17250942 DOI: 10.1016/j.fct.2006.12.001] [Citation(s) in RCA: 36] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/07/2006] [Revised: 09/01/2006] [Accepted: 12/01/2006] [Indexed: 11/16/2022]
Abstract
The mechanisms by which Pb(2+) induces hemolysis are not completely understood. For this reason, the involvement of oxidative stress in the mechanism of Pb(2+)-induced pre-hemolytic lesion was investigated by exposing RBC to Pb(2+) in vitro and then separating the intact non-hemolysed RBC. Oxidative stress was investigated on human RBCs by tert-butyl hydroperoxide-initiated chemiluminescence method (CL). Our results revealed that lead-induced time and concentration-dependent hemolysis and CL time curves showed a very narrow correlation each other. GSH oxidation to GSSG and the stress index also increased significantly. Treatment of lead-exposed RBC with desferrioxamine, an iron-chelating agent or the chain-breaking antioxidant, Trolox, quenched light emission and inhibited hemolysis dramatically. Mannitol and sodium formate, (*)OH scavengers, on the contrary, did not inhibit CL or hemolysis, significantly. These data indicate that lead-induced lipid peroxide formation is mediated by a metal-driven Fenton reaction but do not support the direct involvement of hydroxyl radicals in this process. By contrast, our results revealed a decrease in light emission and decreased hemolysis in the presence of histidine, a singlet oxygen scavenger. Our results suggest that membrane damage and hemolysis of RBC are mediated by Pb(2+) through free radical reactions and that singlet oxygen plays a significant role in this process.
Collapse
Affiliation(s)
- M F Casado
- Pathophysiology Laboratory of Free Radicals, Department of Pathological Sciences, Universidade Estadual de Londrina, 86051-990 Londrina, Brazil
| | | | | | | | | |
Collapse
|
21
|
Wickerham DL, Costantino JP, Vogel V, Cronin W, Cecchini R, Atkins J, Bevers T, Fehrenbacher L, McCaskill-Stevens W, Wolmark N. The study of tamoxifen and raloxifene (STAR): Initial findings from the NSABP P-2 breast cancer prevention study. J Clin Oncol 2006. [DOI: 10.1200/jco.2006.24.18_suppl.lba5] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
LBA5 Background: The STAR trial was designed to compare raloxifene to tamoxifen in terms of relative effect on invasive breast cancer risk and on other beneficial and detrimental outcomes associated with the use of tamoxifen. Methods: The trial opened on 7-1-1999, and accrual was completed November 4, 2004, with 19,747 women enrolled. To be eligible, a woman had to be postmenopausal with a 5-year predicted breast cancer risk of 1.66% as determined by the modified Gail model. Women were randomized and treated in a double-blinded fashion to receive 5 yr of therapy with either 20 mg per day of tamoxifen or 60 mg per day of raloxifene. The protocol-defined monitoring plan called for a final analysis and release of findings when 327 invasive breast cancer cases had been diagnosed in the total population. The mean age of the population at the time of entry into this trial was 58 yr, and the mean 5-yr risk of breast cancer was 4.04%. 93.5% of the women were white; 51.5% had a hysterectomy before entry into the study; 9.2% had a history of LCIS; 71.1% had at least one first-degree relative with a history of breast cancer. The average time on the study is 47 months. Results: There was no difference between the treatment groups in terms of effect on invasive breast cancer: 163 cases in women assigned to tamoxifen and 167 in women assigned to raloxifene (RR = 1.02, 95% CI = 0.82–1.27). The risk of invasive uterine malignancies was 40% less in the raloxifene group (36 in women assigned tamoxifen and 23 in women assigned raloxifene [RR = 0.62, 95% CI = 0.35–1.08]). The risk of non invasive breast cancer was less in the tamoxifen group (57 cases in those assigned to tamoxifen and 81 in those assigned to raloxifene [RR = 1.41, 95% CI = 1.00–2.02]). There were no significant differences between the treatment groups for any of the other invasive cancer sites or for cardiac events, osteoporotic fractures, or deaths. There were fewer thromboembolic events in women taking raloxifene than in those taking tamoxifen. Conclusions: Raloxifene is an effective alternative to tamoxifen for reducing the incidence of invasive breast cancer in postmenopausal women at increased risk of developing the disease and is associated with fewer endometrial cancers, deep vein thromboses, and pulmonary emboli. [Table: see text]
Collapse
Affiliation(s)
- D. L. Wickerham
- National Surgical Adjuvant Breast & Bowel Project, Pittsburgh, PA; NSABP Biostatistical Center, Pittsburgh, PA; University of Pittsburgh, Pittsburgh, PA; Southeast Cancer Control Consortium, Inc., Winston-Salem, NC; M. D. Anderson Cancer Center, Houston, TX; Kaiser Permanente, Vallejo, CA; National Cancer Institute, Bethesda, MD; NSABP & Allegheny General Hospital, Pittsburgh, PA
| | - J. P. Costantino
- National Surgical Adjuvant Breast & Bowel Project, Pittsburgh, PA; NSABP Biostatistical Center, Pittsburgh, PA; University of Pittsburgh, Pittsburgh, PA; Southeast Cancer Control Consortium, Inc., Winston-Salem, NC; M. D. Anderson Cancer Center, Houston, TX; Kaiser Permanente, Vallejo, CA; National Cancer Institute, Bethesda, MD; NSABP & Allegheny General Hospital, Pittsburgh, PA
| | - V. Vogel
- National Surgical Adjuvant Breast & Bowel Project, Pittsburgh, PA; NSABP Biostatistical Center, Pittsburgh, PA; University of Pittsburgh, Pittsburgh, PA; Southeast Cancer Control Consortium, Inc., Winston-Salem, NC; M. D. Anderson Cancer Center, Houston, TX; Kaiser Permanente, Vallejo, CA; National Cancer Institute, Bethesda, MD; NSABP & Allegheny General Hospital, Pittsburgh, PA
| | - W. Cronin
- National Surgical Adjuvant Breast & Bowel Project, Pittsburgh, PA; NSABP Biostatistical Center, Pittsburgh, PA; University of Pittsburgh, Pittsburgh, PA; Southeast Cancer Control Consortium, Inc., Winston-Salem, NC; M. D. Anderson Cancer Center, Houston, TX; Kaiser Permanente, Vallejo, CA; National Cancer Institute, Bethesda, MD; NSABP & Allegheny General Hospital, Pittsburgh, PA
| | - R. Cecchini
- National Surgical Adjuvant Breast & Bowel Project, Pittsburgh, PA; NSABP Biostatistical Center, Pittsburgh, PA; University of Pittsburgh, Pittsburgh, PA; Southeast Cancer Control Consortium, Inc., Winston-Salem, NC; M. D. Anderson Cancer Center, Houston, TX; Kaiser Permanente, Vallejo, CA; National Cancer Institute, Bethesda, MD; NSABP & Allegheny General Hospital, Pittsburgh, PA
| | - J. Atkins
- National Surgical Adjuvant Breast & Bowel Project, Pittsburgh, PA; NSABP Biostatistical Center, Pittsburgh, PA; University of Pittsburgh, Pittsburgh, PA; Southeast Cancer Control Consortium, Inc., Winston-Salem, NC; M. D. Anderson Cancer Center, Houston, TX; Kaiser Permanente, Vallejo, CA; National Cancer Institute, Bethesda, MD; NSABP & Allegheny General Hospital, Pittsburgh, PA
| | - T. Bevers
- National Surgical Adjuvant Breast & Bowel Project, Pittsburgh, PA; NSABP Biostatistical Center, Pittsburgh, PA; University of Pittsburgh, Pittsburgh, PA; Southeast Cancer Control Consortium, Inc., Winston-Salem, NC; M. D. Anderson Cancer Center, Houston, TX; Kaiser Permanente, Vallejo, CA; National Cancer Institute, Bethesda, MD; NSABP & Allegheny General Hospital, Pittsburgh, PA
| | - L. Fehrenbacher
- National Surgical Adjuvant Breast & Bowel Project, Pittsburgh, PA; NSABP Biostatistical Center, Pittsburgh, PA; University of Pittsburgh, Pittsburgh, PA; Southeast Cancer Control Consortium, Inc., Winston-Salem, NC; M. D. Anderson Cancer Center, Houston, TX; Kaiser Permanente, Vallejo, CA; National Cancer Institute, Bethesda, MD; NSABP & Allegheny General Hospital, Pittsburgh, PA
| | - W. McCaskill-Stevens
- National Surgical Adjuvant Breast & Bowel Project, Pittsburgh, PA; NSABP Biostatistical Center, Pittsburgh, PA; University of Pittsburgh, Pittsburgh, PA; Southeast Cancer Control Consortium, Inc., Winston-Salem, NC; M. D. Anderson Cancer Center, Houston, TX; Kaiser Permanente, Vallejo, CA; National Cancer Institute, Bethesda, MD; NSABP & Allegheny General Hospital, Pittsburgh, PA
| | - N. Wolmark
- National Surgical Adjuvant Breast & Bowel Project, Pittsburgh, PA; NSABP Biostatistical Center, Pittsburgh, PA; University of Pittsburgh, Pittsburgh, PA; Southeast Cancer Control Consortium, Inc., Winston-Salem, NC; M. D. Anderson Cancer Center, Houston, TX; Kaiser Permanente, Vallejo, CA; National Cancer Institute, Bethesda, MD; NSABP & Allegheny General Hospital, Pittsburgh, PA
| |
Collapse
|
22
|
Land SR, Kopec J, Cecchini R, Ganz PA, Wieand H, Colangelo L, Sharif S, Kuebler JP, Costantino J, Wolmark N. Patient-reported neurotoxicity with FULV versus FLOX in patients with stage II or III carcinoma of the colon: Results of NSABP Protocol C-07. J Clin Oncol 2006. [DOI: 10.1200/jco.2006.24.18_suppl.3564] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
3564 Background: NSABP Phase III Protocol C-07 compared the efficacy of FULV versus FLOX in patients with stage II or III colon cancer. The definitive analysis revealed an increase in 3-year disease-free survival from 71.6% to 76.5% (HR=0.79, p=0.004) in favor of FLOX. The present study compares patient-reported neurotoxicity between the treatment groups. Methods: Patients were randomized to either FULV (5-FU, 500 mg/m2 iv bolus weekly x 6; LV, 500 mg/m2 iv weekly x 6, each 8-week cycle x 3) or FLOX (FULV with oxaliplatin 85 mg/m2 iv administered on weeks 1, 3 and 5 of each 8-week cycle x 3). A subset of patients (planned sample size 400) at select institutions completed the validated FACT/GOG Oxaliplatin-Specific Neurotoxicity Scale (NTX-12) at baseline, week 4 of cycle 2, and at 6, 12 and 18 months. Mean NTX-12 scores were compared between treatments at 18 months using a t-test and longitudinally with mixed effects modeling. Item responses were compared between treatments with logistic regression. Results: From February 2000 to July 2001, 395 patients with follow-up (206 FULV, 189 FLOX) were enrolled in the neurotoxicity study. They were comparable by disease stage and site, age, and sex to the 759 concurrently accrued C-07 patients not in the sub-study (data not shown). NTX-12 form submission rates were high (with a low of 77% at 12 months). Mean neurotoxicity was higher in the oxaliplatin arm throughout the period of study (p<0.0001) and remained higher at 18 months (p=0.009). During therapy, FLOX patients experienced significant increases in hand/foot neuropathy and overall weakness, and an improvement in hearing ( Table ). At 18 months, hand neurotoxicity resolved, but patients who received oxaliplatin experienced ringing in the ears and continued foot discomfort. Conclusions: This presentation provides the first public review of the severity and persistence of neurotoxicity associated with oxaliplatin in this study. [Table: see text] [Table: see text]
Collapse
Affiliation(s)
- S. R. Land
- University of Pittsburgh, Pittsburgh, PA; University of British Columbia, Vancouver, BC, Canada; UCLA, Los Angeles, CA; National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA; CCOP, Columbus, OH; NSABP, Pittsburgh, PA
| | - J. Kopec
- University of Pittsburgh, Pittsburgh, PA; University of British Columbia, Vancouver, BC, Canada; UCLA, Los Angeles, CA; National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA; CCOP, Columbus, OH; NSABP, Pittsburgh, PA
| | - R. Cecchini
- University of Pittsburgh, Pittsburgh, PA; University of British Columbia, Vancouver, BC, Canada; UCLA, Los Angeles, CA; National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA; CCOP, Columbus, OH; NSABP, Pittsburgh, PA
| | - P. A. Ganz
- University of Pittsburgh, Pittsburgh, PA; University of British Columbia, Vancouver, BC, Canada; UCLA, Los Angeles, CA; National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA; CCOP, Columbus, OH; NSABP, Pittsburgh, PA
| | - H. Wieand
- University of Pittsburgh, Pittsburgh, PA; University of British Columbia, Vancouver, BC, Canada; UCLA, Los Angeles, CA; National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA; CCOP, Columbus, OH; NSABP, Pittsburgh, PA
| | - L. Colangelo
- University of Pittsburgh, Pittsburgh, PA; University of British Columbia, Vancouver, BC, Canada; UCLA, Los Angeles, CA; National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA; CCOP, Columbus, OH; NSABP, Pittsburgh, PA
| | - S. Sharif
- University of Pittsburgh, Pittsburgh, PA; University of British Columbia, Vancouver, BC, Canada; UCLA, Los Angeles, CA; National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA; CCOP, Columbus, OH; NSABP, Pittsburgh, PA
| | - J. P. Kuebler
- University of Pittsburgh, Pittsburgh, PA; University of British Columbia, Vancouver, BC, Canada; UCLA, Los Angeles, CA; National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA; CCOP, Columbus, OH; NSABP, Pittsburgh, PA
| | - J. Costantino
- University of Pittsburgh, Pittsburgh, PA; University of British Columbia, Vancouver, BC, Canada; UCLA, Los Angeles, CA; National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA; CCOP, Columbus, OH; NSABP, Pittsburgh, PA
| | - N. Wolmark
- University of Pittsburgh, Pittsburgh, PA; University of British Columbia, Vancouver, BC, Canada; UCLA, Los Angeles, CA; National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA; CCOP, Columbus, OH; NSABP, Pittsburgh, PA
| |
Collapse
|
23
|
Cecchini AL, Soares AM, Cecchini R, de Oliveira AHC, Ward RJ, Giglio JR, Arantes EC. Effect of crotapotin on the biological activity of Asp49 and Lys49 phospholipases A(2) from Bothrops snake venoms. Comp Biochem Physiol C Toxicol Pharmacol 2004; 138:429-36. [PMID: 15536050 DOI: 10.1016/j.cca.2004.07.010] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/02/2004] [Revised: 07/07/2004] [Accepted: 07/14/2004] [Indexed: 11/25/2022]
Abstract
Myonecrosis, in addition to edema and other biological manifestations, are conspicuous effects of Bothrops snake venoms, some of them caused by phospholipases A(2) (PLA(2)s). Asp49-PLA(2)s are catalytically active, whereas Lys49-PLA(2)s, although highly toxic, have little or no enzymatic activity upon artificial substrates, due to a substitution of lysine for aspartic acid at position 49. Crotapotin (CA), the acidic counterpart of crotoxin PLA(2) (CB), is a PLA(2)-like protein from Crotalus durissus terrificus snake venom, and is considered a chaperone protein for CB, able to increase its lethality about ten fold, but to inhibit the formation of the rat paw edema induced by carrageenin and by snake venoms. In this study, we demonstrate that CA significantly inhibits the edema induced by BthTX-I (23% inhibition), BthTX-II (27%), PrTX-I (25%), PrTX-III (35%) and MjTX-II (10%) on the mouse paw. CK levels evoked by isolated Asp49 or Lys49-PLA(2)s were reduced by 40% to 54% in the presence of CA and, in all cases, the membrane damaging activity of the toxins was also reduced. Circular dichroism spectra of the PLA(2)s in the presence and absence of CA showed that there was not any detectable secondary structural modification due to association between CA and the myotoxins. However, Fourier Transformed Infrared (FT-IR) analysis indicated that ionic and hydrophobic contacts contributed to stabilize this interaction.
Collapse
Affiliation(s)
- A L Cecchini
- Depto de Física e Química, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, USP, Brazil
| | | | | | | | | | | | | |
Collapse
|
24
|
Arantes E, Cecchini A, Soares A, Cecchini R, Vieira C, Giglio J. 243 Effect of crotapotin on the biological activity of D49 and K49 bothrops PLA2. Toxicol Lett 2003. [DOI: 10.1016/s0378-4274(03)90242-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
25
|
Marani M, Manenti F, Di Luca M, Cecchini R, Martello M, Kulurianu K. Is icodextrin peritonitis a reaction to bacterial endotoxins? Perit Dial Int 2002; 22:736-7. [PMID: 12556083] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/28/2023] Open
|
26
|
Baldassarri L, Cecchini R, Bertuccini L, Ammendolia MG, Iosi F, Arciola CR, Montanaro L, Di Rosa R, Gherardi G, Dicuonzo G, Orefici G, Creti R. Enterococcus spp. produces slime and survives in rat peritoneal macrophages. Med Microbiol Immunol 2001; 190:113-20. [PMID: 11827199 DOI: 10.1007/s00430-001-0096-8] [Citation(s) in RCA: 109] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Enterococcal clinical isolates were investigated for the ability to form biofilm on inert surfaces, as a measure of slime production, in an attempt to find new possible virulence factors for these microorganisms. This property was commonly found among Enterococcus faecalis. Also E. faecium isolates were able to form biofilm, although to a lesser extent; for this species, however, biofilm formation seemed more frequently associated with isolates from infection rather than with environmental strains or isolates from healthy individuals. Biofilm formation was strongly affected by the presence of an additional carbohydrate source in the medium, or by iron deprivation, indicating a role of slime for survival in stressful conditions. Slime-producing E. faecalis were able to survive inside peritoneal macrophages for extended periods compared to slime-negative strains or to slime-positive bacteria grown in conditions depressing slime production. In particular, slime-producing and slime-negative cells showed a decrease of 1 and 2 log units, respectively, at 1 h after infection; slime-negative cells were then rapidly killed, with clearance of bacterial cells at 24 h. Slime-producing bacteria persisted up to 48 h, which was the last time point examined, as after that time viability of both infected and non-infected macrophages started to decline. Scanning electron microscopy observations showed the presence of abundant amorphous extracellular material, of possible polysaccharide nature, embedding bacterial cells to form a multilayered biofilm. Even in conditions not supporting biofilm formation, bacterial cells appeared capsulated, suggesting that capsule and slime might represent different structures. Genes belonging to the epa locus or to a putative icaA homolog did not seem to be involved in synthesis and export of slime.
Collapse
Affiliation(s)
- L Baldassarri
- Laboratorio di Ultrastrutture, Istituto Superiore di Sanità, Rome, Italy.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
27
|
Abstract
Oxidative stress as a mediator of hepatic tissue damage concurrent with Leishmania (L.) chagasi infection was investigated. Chemiluminescence in liver supernatant of hamsters infected with Leishmania (L.) chagasi showed a ratio of 1.53/ mg protein and 2.10/liver weight 90 days after infection when compared with the control. The malondialdehyde (MDA) levels also increased significantly both with and without addition of Fe3+/ascorbic acid in the reaction mixture, with a ratio of 2.12 and 1.55/mg protein or 2.91 and 2.12/liver weight, respectively. The parasite burden in the spleen, as a measure of infection severity, was 9.1+/-1.33 x 10(8) parasites/organ. On the 10th day of infection, the chemiluminescence also was significantly higher in infected hamsters than in the controls (ratio = 1.36/mg protein or 1.34/liver weight); however, the MDA levels were not different from those of controls. After 90 days of infection, significant correlations were observed between chemiluminescence and MDA concentration with and without the presence of Fe3+/ascorbic acid (r = 0.54, P = 0.0001; r = 0.56, P = 0.0001; respectively). The high infection/control ratio of both chemiluminescence and MDA concentration and the significant correlation between those events strongly indicate the occurrence of oxidative stress and lipid peroxidation as a mechanism of liver damage in cases of chronic infection by L. chagasi. The significant increase in chemiluminescence at 10 days of infection demonstrates that oxidative stress occurs very early, first consuming the antioxidants and then inducing lipid peroxidative damage later in the chronic stage of this disease.
Collapse
Affiliation(s)
- F J Oliveira
- Department of Pathological Science, University of Londrina, Parana, Brasil
| | | |
Collapse
|
28
|
Avilés G, Cecchini R, Harrington ME, Cichero J, Asis R, Rios C. Aedes aegypti in Córdoba Province, Argentina. J Am Mosq Control Assoc 1997; 13:255-258. [PMID: 9383767] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/22/2023]
Abstract
In 1955, the area infested by Aedes aegypti in Argentina was estimated as 1,500,000 km2; and in 1963, the species was considered to be eradicated from Argentina. In 1995, the Argentine Ministry of Health reported reinfestation by Ae. aegypti. During 1994-95, the Ministry of Health of Córdoba Province, Zoonosis Department, established a surveillance system for Ae. aegypti in Córdoba Province, Argentina. This report is a summary of results obtained thus far. In total, 74 localities in Córdoba Province were sampled during August 1994-April 1996, resulting in 5 positives (6.7%): Villa María city, Villa Nueva, and Córdoba city in 1995, and Juarez Celman and Jesús María in 1996. In Villa María and Villa Nueva, Ae. aegypti was present until June 1995 (autumn) and reappeared in December 1995. In Córdoba city, Ae. aegypti was eliminated from the only positive house in May 1995, but it reappeared in March 1996. Reappearance of Ae. aegypti in this temperate area in early summer may have been due to the survival of individuals during winter and not to reintroduction during summertime. The last previous active surveillance for Ae. aegypti in Córdoba Province was carried out more than 30 years ago.
Collapse
Affiliation(s)
- G Avilés
- Instituto Nacional de Enfermedades Virales Humanas Dr. Julio I Maiztegui, Monteagudo, Pergamino, Argentina
| | | | | | | | | | | |
Collapse
|
29
|
Evans PJ, Cecchini R, Halliwell B. Oxidative damage to lipids and alpha 1-antiproteinase by phenylbutazone in the presence of haem proteins: protection by ascorbic acid. Biochem Pharmacol 1992; 44:981-4. [PMID: 1530664 DOI: 10.1016/0006-2952(92)90131-2] [Citation(s) in RCA: 29] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Abstract
Phenylbutazone is an anti-inflammatory drug with numerous side-effects that restrict its clinical use. In the presence of myoglobin, or of haemoglobin plus H2O2, phenylbutazone accelerates the peroxidation of lipids (arachidonic acid and rat liver microsomes) and causes the inactivation of alpha-antiproteinase, so that this protein can no longer inhibit elastase. We propose that haem proteins oxidize phenylbutazone into a damaging free radical. Ascorbic acid inhibits these pro-oxidant actions of phenylbutazone.
Collapse
Affiliation(s)
- P J Evans
- Department of Biochemistry, University of London Kings College, U.K
| | | | | |
Collapse
|
30
|
Aruoma OI, Smith C, Cecchini R, Evans PJ, Halliwell B. Free radical scavenging and inhibition of lipid peroxidation by beta-blockers and by agents that interfere with calcium metabolism. A physiologically-significant process? Biochem Pharmacol 1991; 42:735-43. [PMID: 1678258 DOI: 10.1016/0006-2952(91)90030-9] [Citation(s) in RCA: 67] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
It has been proposed that beta-blockers and agents affecting Ca2+ metabolism might exert cardioprotective actions because of their ability to act as antioxidants in vivo. The feasibility of this proposal was tested by examining the reaction of a series of such compounds with various oxygen-derived species. None of the compounds tested was sufficiently reactive with superoxide radical, hydrogen peroxide or hypochlorous acid for scavenging of these species to be feasible in vivo at the drug concentrations present in patients given the usual therapeutic doses. All the drugs tested were powerful scavengers of hydroxyl radical except for flunarizine, which stimulated iron ion-dependent hydroxyl radical generation from hydrogen peroxide. However, none of the drugs significantly inhibited production of hydroxyl radicals in this system. Propranolol, verapamil and flunarizine had significant inhibitory effects on the peroxidation of rat liver microsomes in the presence of iron ions and ascorbic acid. All three compounds exerted weaker inhibitory effects on peroxidation of arachidonic acid caused by a mixture of myoglobin and H2O2: pindolol stimulated peroxidation in this system. It is concluded that the ability of beta-blockers and "Ca(2+)-blockers" to inhibit lipid peroxidation varies with the lipid substrate used and the mechanism by which peroxidation is induced. We conclude that suggestions that beta-blockers and "Ca(2+)-blockers" exert antioxidant effects in vivo are not well founded, although there is a possibility that verapamil and propranolol might have some inhibitory effects against peroxidation if they accumulate in membranes to a sufficiently-high concentration in vivo. We could not confirm the reported ability of propranolol to inhibit the enzyme xanthine oxidase.
Collapse
Affiliation(s)
- O I Aruoma
- Department of Biochemistry, University of London, King's College, U.K
| | | | | | | | | |
Collapse
|
31
|
Abstract
Ergothioneine is a product of plant origin that accumulates in animal tissues. Its suggested ability to act as an antioxidant has been evaluated. Ergothioneine is a powerful scavenger of hydroxyl radicals (.OH) and an inhibitor of iron or copper ion-dependent generation of .OH from hydrogen peroxide (H2O2). It is also an inhibitor of copper ion-dependent oxidation of oxyhaemoglobin, and of arachidonic acid peroxidation promoted by mixtures of myoglobin (or haemoglobin) and H2O2. Ergothioneine is a powerful scavenger of hypochlorous acid, being able to protect alpha 1-antiproteinase against inactivation by this molecule. By contrast, it does not react rapidly with superoxide (O2-) or hydrogen peroxide (H2O2) and it does not inhibit microsomal lipid peroxidation in the presence of iron ions. Overall, our results show that ergothioneine at the concentrations present in vivo could act as an antioxidant.
Collapse
Affiliation(s)
- D Akanmu
- Department of Biochemistry, University of London King's College, United Kingdom
| | | | | | | |
Collapse
|
32
|
Aruoma OI, Akanmu D, Cecchini R, Halliwell B. Evaluation of the ability of the angiotensin-converting enzyme inhibitor captopril to scavenge reactive oxygen species. Chem Biol Interact 1991; 77:303-14. [PMID: 1849048 DOI: 10.1016/0009-2797(91)90039-a] [Citation(s) in RCA: 62] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
Captopril, an inhibitor of angiotensin-converting enzyme, has been suggested to have additional cardioprotective action because of its ability to act as an antioxidant. The rates of reaction of captopril with several biologically-relevant reactive oxygen species were determined. Captopril reacts slowly, if at all, with superoxide (rate constant less than 10(3) M-1 s-1) or hydrogen peroxide (rate constant less than M-1 s-1). It does not inhibit peroxidation of lipids stimulated by iron ions and ascorbate or by the myoglobin/H2O2 system. Indeed, mixtures of ferric ion and captopril can stimulate lipid peroxidation. Captopril reacts rapidly with hydroxyl radical (rate constant greater than 10(9) M-1 s-1) but might be unlikely to compete with most biological molecules for OH because of the low concentration of captopril that can be achieved in vivo during therapeutic use. Captopril did not significantly inhibit iron ion-dependent generation of hydroxyl radicals from hydrogen peroxide. By contrast, captopril is a powerful scavenger of hypochlorous acid: it was able to protect alpha 1-antiproteinase (alpha 1 AP) against inactivation by this species and to prevent formation of chloramines from taurine. We suggest that the antioxidant action of captopril in vivo is likely to be limited, and may be restricted to protection against damage by hypochlorous acid derived from the action of neutrophil myeloperoxidase.
Collapse
Affiliation(s)
- O I Aruoma
- Department of Biochemistry, University of London King's College, U.K
| | | | | | | |
Collapse
|
33
|
Puppo A, Cecchini R, Aruoma OI, Bolli R, Halliwell B. Scavenging of hypochlorous acid and of myoglobin-derived oxidants by the cardioprotective agent mercaptopropionylglycine. Free Radic Res Commun 1990; 10:371-81. [PMID: 2175285 DOI: 10.3109/10715769009149906] [Citation(s) in RCA: 26] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
Mercaptopropionylglycine (MPG) has a marked cardioprotective action in several model systems of ischaemia-reoxygenation injury. Suggested mechanisms of action include scavenging of hydroxyl radical and of hypochlorous acid and reacting with an oxidant formed by reaction of myoglobin with H2O2, thereby slowing lipid peroxidation stimulated by myoglobin-H2O2 mixtures. This oxidant seems not to be singlet O2 or hydroxyl radical. Studies in vitro show that scavenging of hypochlorous acid is a feasible mechanism of cardioprotective action for MPG in vivo in ischaemia/reperfusion systems to which neutrophil-mediated injury contributes. However, the poor ability of MPG to inhibit lipid peroxidation stimulated by myoglobin/H2O2 mixtures and its ability to increase iron ion release from myoglobin in the presence of a large excess of H2O2 suggests that MPG is unlikely to protect the myocardium by interfering with oxidants produced by the myoglobin-H2O2 system.
Collapse
Affiliation(s)
- A Puppo
- Laboratoire de Biologie Végètale, Université de Nice, France
| | | | | | | | | |
Collapse
|
34
|
Cecchini R, Aruoma OI, Halliwell B. The action of hydrogen peroxide on the formation of thiobarbituric acid-reactive material from microsomes, liposomes or from DNA damaged by bleomycin or phenanthroline. Artefacts in the thiobarbituric acid test. Free Radic Res Commun 1990; 10:245-58. [PMID: 1705234 DOI: 10.3109/10715769009149893] [Citation(s) in RCA: 39] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
Incubation of rat-liver microsomes, previously azide-treated to inhibit catalase, with H2O2 caused a loss of cytochrome P-450 but not of cytochrome b5. This loss of P-450 was not prevented by scavengers of hydroxyl radical, chain-breaking antioxidants or metal ion-chelating agents. Application of the thiobarbituric acid (TBA) assay to the reaction mixture suggested that H2O2 induces lipid peroxidation, but this was found to be due largely or completely to an effect of H2O2 on the TBA assay. By contrast, addition of ascorbic acid and Fe(III) to the microsomes led to lipid peroxidation and P-450 degradation: both processes were inhibited by chelating agents and chain-breaking antioxidants, but not by hydroxyl radical scavengers. H2O2 inhibited ascorbate/Fe(III)-induced microsomal lipid peroxidation, but part of this effect was dues to an action of H2O2 in the TBA test itself. H2O2 also decreased the colour measured after carrying out the TBA test upon authentic malondialdehyde, tetraethoxypropane, a DNA-Cu2+/o-phenanthroline system in the presence of a reducing agent, ox-brain phospholipid liposomes in the presence of Fe(III) and ascorbate, or a bleomycin-ion iron/DNA/ascorbate system. Caution must be used in interpreting the results of TBA tests upon systems containing H2O2.
Collapse
Affiliation(s)
- R Cecchini
- Department of Biochemistry, King's College, London, UK
| | | | | |
Collapse
|
35
|
|